SARcopenia Assessment in Hypertension: The SARAH Study.

Murat Kara,Özgür Kara, Yasin Ceran,Bayram Kaymak,Tuğçe Cansu Kaya,Beyza Nur Çıtır,Mahmut Esad Durmuş, Esra Durmuşoğlu,Sarah Razaq,Yahya Doğan, Dia Shehab,Salem A Alkandari,Ahmad J Abdulsalam,Ayşe Merve Ata,Esra Gizem Koyuncu,Evrim Coşkun, Gökhan Turan,Banu Dilek,Mehmet Ali Culha,Pelin Yıldırım,Kamal Mezian,Beril Doğu,Gamze Kılıç,Zeliha Ünlü, Jorge Barbosa, Sérgio Pinho,Pelin Analay,Deniz Palamar,Orhan Güvener,Hasan Ocak,Fevziye Ünsal Malas, Murat Baday,Banu Çakır,Levent Özçakar

American journal of physical medicine & rehabilitation（2023）

引用 9|浏览20

暂无评分

摘要

Hypertension was associated with increased risk of sarcopenia at least 2 times. Among antihypertensives, while angiotensin-converting enzyme inhibitors had higher muscle function values, angiotensin II receptor blockers had higher muscle mass and physical performance values only in females.

查看译文

关键词

Grip Strength,Angiotensin-Converting Enzyme Inhibitors,Muscle Function,Quadriceps,Ultrasound

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要